Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 314
Magel, V, Blum, J, Dolde, X, Leisner, H, Grillberger, K, Khalidi, H, Gardner, I, Ecker, GF, Pallocca, G, Dreser, N & Leist, M 2024, 'Inhibition of Neural Crest Cell Migration by Strobilurin Fungicides and Other Mitochondrial Toxicants', Cells, vol. 13, no. 24, 2057. https://doi.org/10.3390/cells13242057

Li, E, Boujeddaine, N, Houtman, MJC, Maas, RGC, Sluijter, JPG, Ecker, GF, Stary-Weinzinger, A, van Ham, WB & van der Heyden, MAG 2024, 'Development of new Kir2.1 channel openers from propafenone analogues', British Journal of Pharmacology, vol. 182, no. 3, pp. 633-650. https://doi.org/10.1111/bph.17377

Ortega-Vallbona, R, Palomino-Schätzlein, M, Tolosa, L, Benfenati, E, Ecker, GF, Gozalbes, R & Serrano-Candelas, E 2024, 'Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study', International Journal of Molecular Sciences, vol. 25, no. 20, 11154. https://doi.org/10.3390/ijms252011154

Digles, D, Ingles-Prieto, A, Dvorak, V, Mocking, TAM, Goldmann, U, Garofoli, A, Homan, EJ, Di Silvio, A, Azzollini, L, Sassone, F, Fogazza, M, Bärenz, F, Pommereau, A, Zuschlag, Y, Ooms, JF, Tranberg-Jensen, J, Hansen, JS, Stanka, J, Sijben, HJ, Batoulis, H, Bender, E, Martini, R, IJzerman, AP, Sauer, DB, Heitman, LH, Manolova, V, Reinhardt, J, Ehrmann, A, Leippe, P, Ecker, GF, Huber, KVM, Licher, T, Scarabottolo, L, Wiedmer, T & Superti-Furga, G 2024, 'Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily', Frontiers in Pharmacology, vol. 15, 1401599. https://doi.org/10.3389/fphar.2024.1401599

Activities

Showing entries 6 - 10 out of 203

Hypothesis generation for variant effects using a KNIME workflow for ​ automatic mapping of disease-related mutations onto 3D protein structures​

Jiahui Huang , Claire Colas , Gerhard Ecker
ACS Fall 2022
Conference, Poster presentation
21.8.2022 - 21.8.2022

Wie lassen sich Elternschaft und Wissenschaft vereinbaren?

Veronika Wöhrer , Gerhard Ecker , Therese Garstenauer , Benjamin Herr , Alice Leal
Wie lassen sich Elternschaft und Wissenschaft an der Universität Wien vereinbaren?
Panel discussion, round table, Talk or oral contribution
13.6.2022 - 13.6.2022

Arzneistoffentwicklung in Zeiten personalisierter Medizin

Gerhard Ecker
APOKongress - Personalisierte Medizin und Pharmazie
Conference, Talk or oral contribution
19.6.2021 - 19.6.2021

In silico Toxicology - from prediction of transporter interaction profiles to toxicological read across and beyond

Gerhard Ecker
XII EWDD - 12th European Workshop in Drug Design
Conference, Talk or oral contribution
20.5.2019 - 20.5.2019

Research of new TTK kinase inhibitors by using structure-based pharmacophore modelling and docking experiments

Riccardo Martini , Katharina Schwartz , Gerhard Ecker
XII EWDD - 12th European Workshop in Drug Design
Conference, Poster presentation
19.5.2019 - 19.5.2019